- All > Medicine Access and Rational Use > Rational Use
- All > Medicine Access and Rational Use > Selection
- All > Medicine Programme Coordination > Programme Coordination
(2008; 111 pages)
The publication of the Respiratory Drug Guidelines represents the culmination of the efforts of the National Medicines and Therapeutics Committee to publish clinical drug guidelines for common diseases seen in Fiji. These guidelines are targeted for health care settings. It sets the gold standards for the use of respiratory drugs in Fiji. These guidelines have taken into account the drugs available in the Fiji Essential Medicines List (EML) in recommending treatment approaches. All recommended drug therapies are either evidence-based or universally accepted standards.
It is hoped that these guidelines will be used by all health care workers in their daily care of patients suffering from respiratory diseases.